FLT3-ITD POSITIVE ACUTE MYELOİD LEUKEMIA MIMICKING ACUTE PROMYELOCYTIC LEUKEMİA
Objective: Acute myeloid leukemia (AML) is a heterogeneous disease due to genetic abnormalities and differences in immunophenotypes. The diagnosis of AML requires a careful evaluation of clinical morphology, immunophenotyping, cytogenetics, and molecular analyses. 1 In current practice, flow cytomet...
Saved in:
| Main Authors: | Birsen Sahip Yesiralioğlu, Müzeyyen Aslaner Ak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924028633 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RSK1 dependency in FLT3-ITD acute myeloid leukemia
by: Tim Kong, et al.
Published: (2024-11-01) -
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
by: Bai‐Liang He, et al.
Published: (2020-03-01) -
FLT3 inhibition upregulates OCT4/NANOG to promote maintenance and TKI resistance of FLT3-ITD+ acute myeloid leukemia
by: Qi Zhou, et al.
Published: (2025-03-01) -
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
by: Bhavana Bhatnagar, et al.
Published: (2025-04-01) -
FLT3-ITD promotes immune checkpoint CD80 via ROS elevation in acute myeloid leukemia
by: Libo Yan, et al.
Published: (2025-07-01)